Form S-3 COGNITION THERAPEUTICS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Cognition Therapeutics establishes $75 million stock offering program
December 18, 2025 4:22 PM ESTCognition Therapeutics Inc. (NASDAQ: CGTX) entered into an at-the-market equity offering agreement with Jefferies LLC on December 18, 2024, according to a company filing.
Under the sales agreement, Cognition Therapeutics may sell up to $75 million of its common stock through Jefferies, which will... More
Cognition Therapeutics, Inc. (CGTX) files $300M mixed shelf
December 18, 2025 4:09 PM ESTCognition Therapeutics, Inc. (NASDAQ: CGTX) has filed $300,000,000 mixed shelf of:
Common Stock
Preferred Stock
Debt Securities
Warrants
Units
Subscription Rights
